# Oral Gabapentin and Median Nerve Mobilization in the Treatment of Carpal Tunnel Syndrome

> **NCT04285281** · PHASE4 · COMPLETED · sponsor: **Universidad Europea de Madrid** · enrollment: 126 (actual)

## Conditions studied

- Carpal Tunnel Syndrome

## Interventions

- **DRUG:** Gabapentin oral capsules
- **OTHER:** Median nerve neural mobilization

## Key facts

- **NCT ID:** NCT04285281
- **Lead sponsor:** Universidad Europea de Madrid
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2020-08-01
- **Final completion:** 2020-08-10
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04285281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04285281, "Oral Gabapentin and Median Nerve Mobilization in the Treatment of Carpal Tunnel Syndrome". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04285281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*